By 1959, Eugene Kennedy and coworkers had outlined most pathways of phospholipid biosynthesis. In the next four decades, the emphasis was on enzymology and regulation of these pathways. In the last 12 years, several lines of mice with disrupted genes of phospholipid biosynthesis were generated. From this research, we have learned that embryonic lethality occurs in mice that lack choline kinase (CK) a, CTP:phosphocholine cytidylyltransferase a, CTP:phosphoethanolamine cytidylyltransferase, or phosphatidylserine decarboxylase. Whereas mice that lack CK b are viable but develop hindlimb muscular dystrophy and neonatal bone deformity. Mice that lack CTP:phosphocholine cytidylytransferase b have gonadal dysfunction and defective axon branching. Mice that lack phosphatidylethanolamine N-methyltransferase exhibit no phenotype until fed a choline-deficient diet, which leads to rapid liver failure. Future research should extend our knowledge about the function of these and other enzymes of phospholipid biosynthesis.-Vance, D. E., and J. E. Vance. Physiological consequences of disruption of mammalian phospholipid biosynthetic genes. J. Lipid Res. 2009. 50: S132-S137.
Supplementary key words phosphatidylcholineIn 1959, the general outline of biosynthesis of major phospholipids had been established in studies pioneered by Eugene Kennedy (1-3). A key finding was that CTP, not ATP, was the ribonucleoside triphosphate required for phospholipid biosynthesis (1). The next major focus was to purify enzymes involved in phospholipid biosynthesis, many of which were integral membrane proteins. Thus, success was limited. Choline kinase (CK) was purified in 1984 (4), CTP:phosphocholine cytidylyltransferase (CT) was purified in 1987 (5), and the integral membrane protein, phosphatidylethanolamine (PE) N-methyltransferase (PEMT) that converts PE to PC was purified in 1987 (6). Several phospholipid biosynthetic enzymes have never been purified.In the 1970s, investigations into the regulation of phospholipid biosynthesis were initiated. In 1975, primary rat hepatocytes were used to demonstrate that the second enzyme in the Kennedy pathway for PC biosynthesis, CT, catalyzed the rate-limiting step (7). These findings were confirmed under most metabolic conditions (8). In addition, the rate-limiting enzyme of PE synthesis via CDP-ethanolamine was identified as CTP:phosphoethanolamine cytidylyltransferase (ET) (7). A striking regulatory feature of PC biosynthesis is that CT is inactive in the cytosolic fraction of cells but is activated by translocation to membranes (9). Insights into the mechanism of translocation of CT to membranes have been largely provided by Cornell and Northwood (10) and Taneva et al. (11). Studies on regulation of expression of mRNAs encoding CTa have concluded that CTa expression is linked to the cell cycle, cell growth, and differentiation rather than energy metabolism (12).Clearly, significant progress has been made during the last 50 years in understanding the enzymology and regulation of PC biosynthesis. ...